IP Library › Granted Patent US 8,871,200
Granted Patent B2
US 8,871,200 · App. 12/516,440 · Granted Oct 28, 2014

Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method

Inventors: Dmitry Dmitrievich Genkin (Saint-Petersburg, RU); Viktor Veniaminovich Tets (Saint-Petersburg, RU); Georgy Viktorovich Tets (Saint-Petersburg, RU)
Assignee: CLS Therapeutics Limited
A61K38/465A61K38/47A61K38/46A61K38/43A61K9/0031A61K9/0058A61K9/2018A61K9/2054C12Y301/21001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,200
App. No.
12/516,440
Granted
Oct 28, 2014
Kind
B2
Abstract

The invention relates to medicine. The invention provides inventive method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and organs, which method comprises enterally administering DNAse enzyme in a quantity of 20 000-500 000 Kunz units in a day per 1 kg of the body mass. The single dose of the inventive medicinal preparation for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and organs comprises 20 000-500 000 Kunz units of the DNAse enzyme. The oral administration of the above-mentioned important doses of the preparation allows the catalytically significant amount of DNAse to be absorbed into the systemic circulation in such a way that the dose-dependent treating effect thereof is exhibited.

Claims (8)

1. A method for treating a disease associated with increased deoxyribonucleic acid content in extracellular spaces of tissues and organs in a human in need thereof, said method comprising enterally administering to said human a DNASE I enzyme, wherein said enzyme is introduced in doses from 20 000 to 500 000 Kunitz units per 1 kg of the body mass per day.

2. The method according to claim 1 , wherein the DNASE I enzyme is administered orally.

3. The method according to claim 2 , wherein the DNASE I enzyme is contained in a dosage form which provides enzyme release in oral cavity.

4. The method according to claim 2 , wherein the DNASE I enzyme is contained in a dosage form which provides enzyme release in stomach.

5. The method according to claim 2 , wherein the DNASE I enzyme is contained in a dosage form which provides enzyme release in small intestine.

6. The method according to claim 2 , wherein the DNASE I enzyme is contained in a dosage form which provides enzyme release in large intestine.

7. The method according to claim 1 , wherein the DNASE I enzyme is administered rectally.

8. A method for treating age-specific sperm motility impairment in a human in need thereof, said method comprising enterally administering to said human a DNASE enzyme, wherein said enzyme is introduced in doses from 20 000 to 500 000 Kunitz units per 1 kg of the body mass per day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2010
From: GENKIN, DMITRY DMITRIEVICH; TETS, VIKTOR VENIAMINOVICH; TETS, GEORGY VIKTOROVICH
To: CLS THERAPEUTICS LIMITED
Reel/Frame 025358/0338 →
Continuity (1)
Related Publication 20100061971A1 · Mar 11, 2010